Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Oral tofacitinib successfully treated total body hair loss in one patient.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Melatonin helps regulate sleep and may aid in treating various health issues.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

Granulomatous alopecia areata is a rare but real form of hair loss.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

Alopecia areata may be linked to heart issues.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Targeting Vδ1+T-cells may help treat alopecia areata.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Fetal skin has unique immune cells different from adult skin.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.